Oncogenes modulate cell sensitivity to apoptosis induced by glucose deprivation

Maya Kansara1, Michael V Berridge

  • 1Malaghan Institute of Medical Research, PO Box 7060, Wellington South, New Zealand.

Anticancer Research
|August 28, 2004
PubMed
Abstract

Insights

Oncogenes significantly impact cancer cell survival during glucose deprivation. Some oncogenes promote apoptosis, while others, like bcr-abl, offer protection, influencing cancer cell fate.

Area of Science:

  • Oncology
  • Molecular Biology
  • Cell Biology

Background:

  • Tumors exhibit increased glucose uptake, making cancer cells vulnerable to glucose deprivation.
  • Investigated the role of specific oncogenes in sensitizing cells to apoptosis induced by glucose deprivation.

Purpose of the Study:

  • To determine how oncogenes influence cancer cell apoptosis under glucose-deprived conditions.
  • To explore the differential effects of various oncogenes on cell survival and growth during metabolic stress.

Main Methods:

  • Utilized oncogene-transformed 32D cells subjected to glucose deprivation with or without IL-3.
  • Measured glucose uptake using [3H]2-deoxyglucose.
  • Assessed apoptosis via AnnexinV/propidium iodide staining, cell cycle analysis, and Western blotting for MYC expression.

Main Results:

  • v-Hras, v-src, and v-abl enhanced apoptosis in the presence of IL-3 but attenuated it in its absence.
  • bcr-abl conferred significant protection against glucose deprivation-induced apoptosis for 72 hours, irrespective of IL-3.
  • bcl-2 provided mild protection in the presence of IL-3.
  • c-MYC expression correlated with sensitivity to glucose deprivation-induced apoptosis in cells with strongly transforming oncogenes.

Conclusions:

  • Oncogenes exhibit diverse effects on apoptosis during glucose deprivation, with some promoting cell death and others conferring protection.
  • The specific oncogene and cellular context (e.g., presence of IL-3) dictate the outcome of glucose deprivation on cancer cell survival.

Related Concept Videos

Cancer-Critical Genes I: Proto-oncogenes01:33

Cancer-Critical Genes I: Proto-oncogenes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
Cancer-Critical Genes I: Proto-oncogenes01:33

Cancer-Critical Genes I: Proto-oncogenes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
Adaptive Mechanisms in Cancer Cells02:53

Adaptive Mechanisms in Cancer Cells

Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Adaptive Mechanisms in Cancer Cells02:53

Adaptive Mechanisms in Cancer Cells

Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
Cancer-Critical Genes II: Tumor Suppressor Genes01:05

Cancer-Critical Genes II: Tumor Suppressor Genes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...